SCHEMBL19913341

SCHEMBL19913341

N#Cc1c(-n2c3ccccc3c3c(-c4ccccc4-c4ccccc4)cccc32)ccc(-c2ccncc2)c1-n1c2ccccc2c2c(-c3ccccc3-c3ccccc3)cccc21

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SQOR Q9Y6N5 1/20 0.38
ADORA1 P30542 2/20 0.35
ADORA2A P29274 1/20 0.34
CYP11B2 P19099 1/20 0.34
NRP1 O14786 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
HIF1A Q16665 1/20 0.33
HTR6 P50406 2/20 0.33
MEN1 O00255 2/20 0.32
KMT2A Q03164 2/20 0.32
PARP1 P09874 1/20 0.32
PDE10A Q9Y233 4/20 0.32
ALDH1A1 P00352 1/20 0.32
CYP1A2 P05177 1/20 0.32
CYP2C9 P11712 1/20 0.32
CYP2C19 P33261 1/20 0.32
L3MBTL1 Q9Y468 1/20 0.32
POLB P06746 1/20 0.31
RXFP1 Q9HBX9 1/20 0.31
CD274 Q9NZQ7 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19913339 0.87 SQOR (0.39) SQORADORA1ADORA2ASMN1; SMN2MEN1
SCHEMBL21757800 0.87 SQOR (0.40) SQORADORA1ADORA2ACYP11B2NRP1
SCHEMBL19913338 0.85 SQOR (0.40) SQORADORA1ADORA2ACYP11B2HTR6
SCHEMBL19913340 0.85 SQOR (0.40) SQORADORA1ADORA2ACYP11B2SMN1; SMN2
SCHEMBL19909309 0.85 SQOR (0.41) SQORADORA1ADORA2ACYP11B2NRP1
SCHEMBL19913330 0.81 SQOR (0.39) SQORADORA1SMN1; SMN2HIF1AHTR6
SCHEMBL22170439 0.81 SQOR (0.39) SQORADORA1ADORA2ASMN1; SMN2HTR6
SCHEMBL19919660 0.81 SQOR (0.37) SQORSMN1; SMN2HIF1AHTR6PDE10A
SCHEMBL19913322 0.80 SQOR (0.38) SQORADORA1ADORA2ACYP11B2NRP1
SCHEMBL19913334 0.80 HPGD (0.36) SQORCYP11B2NRP1HTR6ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11588114-B2 Organic molecules for use in optoelectronic devices SAMSUNG DISPLAY CO., LTD. (KR) 2023-02-21 US disclosed
US-20200212316-A1 ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES CYNORA GMBH (DE) 2020-07-02 US disclosed
US-10665792-B2 Organic molecules for use in optoelectronic devices CYNORA GMBH (DE) 2020-05-26 US disclosed
US-20180062085-A1 ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES SAMSUNG DISPLAY CO., LTD. (KR) 2018-03-01 US disclosed
US-20180062085-A1 ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES SAMSUNG DISPLAY CO., LTD. (KR) 2018-03-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200212316-A1 ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES OR10J3, OPRM1, OR51E2 SQOR 1580/4885ADORA1 4379/4885ADORA2A 3726/4885
US-10665792-B2 Organic molecules for use in optoelectronic devices OR10J3, CFD, AOX1 SQOR 225/4885ADORA1 4641/4885ADORA2A 4758/4885
US-11588114-B2 Organic molecules for use in optoelectronic devices OR10J3, OPRM1, OR51E2 SQOR 1580/4885ADORA1 4379/4885ADORA2A 3726/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.